Contributions of Mayme Williams to the Elucidation of the Multiple Functions of Plasma Kininogens

• References

• 1 Jacobsen S, Kriz M. Some data on two purified kininogens from human plasma. Br J Pharmacol 1967; 29: 25-36
• 2 Meier HL, Pierce JV, Colman RW, Kaplan AP. Activation and function of human Hageman factor: The role of high molecular weight kininogen and prekallikrein. J Clin Invest 1977; 60: 18-31
• 3 Mandle RJ, Colman RW, Kaplan AP. Identification of prekallikrein and high molecular weight kininogen as a complex in human plasma. Proc Natl Acad Sci USA 1976; 73: 4179-4183
• 4 Thompson RE, Mandle Jr R, Kaplan AP. Studies of binding of prekallikrein and factor XI to high molecular weight kininogen and its light chain. Proc Natl Acad Sci USA 1979; 76: 4862-4866
• 5 Schapira M, Scott CF, Colman RW. Protection of human plasma kallikrein from inactivation by Cl-inhibitor and other protease inhibitors: The role of high molecular weight kininogen. Biochemistry 1981; 20: 2738-2743
• 6 Scott CF, Schapira M, James HL, Cohen AB, Colman RW. Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha-1-protease inhibitor and protective effect of high molecular weight kininogen. J Clin Invest 1982; 69: 844-852
• 7 Schmaier AH, Silver L, Adams AL. et al The effect of high molecular weight kininogen on surface-adsorbed fibrinogen. Thromb Res 1984; 33: 51-67
• 8 Gustafson EJ, Lukasiewicz H, Wachtfogel YT. et al High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets. J Cell Biol 1989; 109: 377-387
• 9 Sinha D, Seaman FS, Koshy A, Knight LC, Walsh PN. Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI. J Clin Invest 1984; 73: 1550-1556
• 10 Gustafson EJ, Schmaier AH, Wachtfogel YT. et al Human neutrophils contain and bind high molecular weight kininogen. J Clin Invest 1989; 84: 28-35
• 11 Puri RN, Zhou F-X, Hu C-J, Colman RF, Colman RW. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets. Blood 1991; 77: 500-507
• 12 Meloni FJ, Schmaier AH. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation. J Biol Chem 1991; 266: 6786-6794
• 13 Ohkubo I, Kurachi K, Takasawa T, Shiokawa H, Sasaki M. Isolation of a human cDNA for alpha-2 thiol protease inhibitor and its identity with low molecular weight kininogen. Biochemistry 1984; 23: 5691-5697
• 14 Schmaier AH, Bradford H, Silver LD. et al High molecular weight kininogen is an inhibitor of platelet calpain. J Clin Invest 1986; 77: 1565-1573
• 15 Bradford HN, Schmaier AH, Colman RW. Kinetics of inhibition of platelet calpain II by human kininogens. Biochem J 1990; 270: 83-90
• 16 Colman RW, Bagdasarian A, Talamo RC. et al Williams Trait: Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor dependent pathways. J Clin Invest 1975; 56: 1650-1662
• 17 Scott CF, Colman RW. Function and immunochemistry of prekallikrein high molecular weight kininogen complex in plasma. J Clin Invest 1980; 65: 413-421
• 18 Schapira M, Scott CF, James A. et al High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors. Biochemistry 1982; 21: 567-572
• 19 Kitamura N, Kitagawa H, Fukushima D, Takagaki Y, Miyata T. Structural organization of the kininogen gene and a model for its evolution. J Biol Chem 1985; 260: 8610-8617
• 20 Scott CF, Silver LD, Schapira M, Colman RW. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity: Evidence that this molecule exists as a procofactor. J Clin Invest 1984; 73: 954-962
• 21 Wiggins RC. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein. J Biol Chem 1983; 258: 8963-8970
• 22 Villanueva GB, Leung L, Bradford H, Colman RW. Conformation of high molecular weight kininogen: Effects of kallikrein and factor XIa cleavage. Biochem Biophys Res Commun 1989; 158: 72-79
• 23 Kleniewski J, Dingle SS, Donaldson VH. Comparison of properties of monoclonal and polyclonal antibodies against the light chain of human high molecular weight kininogen. J Lab Clin Med 1988; 111: 93-103
• 24 Scott CF, Silver L, Purdon AD, Colman RW. Cleavage of human high molecular weight kininogen by factor XIa in vitro: effect on structure and function. J Biol Chem 1985; 260: 10856-10863
• 25 Vroman L, Adams AL. Findings with the recording ellipsometer suggesting rapid exchange of plasma proteins at liquid/solid interfaces. Surface Sci 1969; 16: 438-446
• 26 Brash JL, Scott CF, ten Hove P, Wojciechowski P, Colman RW. Mechanism of transient absorption of fibrinogen from plasma to solid surfaces: Role of the contact and fibrinolytic systems. Blood 1988; 71: 932-939
• 27 Lindon JN, McManama G, Kushner L, Merrill EW, Salzman EW. Does the conformation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces?. Blood 1986; 68: 355-362
• 28 Schmaier AH, Zuckerberg A, Silverman C, Kuchibhotla J, Tuszynski GP, Colman RW. High molecular weight kininogen: a secreted platelet protein. J Clin Invest 1983; 71: 477-489
• 29 Schmaier AH, Smith PM, Purdon AD, White JG, Colman RW. High molecular weight kininogen: Localization in the unstimulated and activated platelet and activation by a platelet calpain(s). Blood 1986; 67: 119-130
• 30 Gustafson EJ, Schutsky D, Knight LC, Schmaier AH. High molecular weight kininogen binds to unstimulated platelets. J Clin Invest 1986; 78: 310-318
• 31 Greengard JS, Griffin JH. Receptors for high molecular weight kininogen on stimulated washed human platelets. Biochemistry 1984; 23: 6863-6869
• 32 Schapira M, Despland E, Scott CF, Boxer LA, Colman RW. Purified human plasma kallikrein aggregates human blood neutrophils. J Clin Invest 1982; 69: 1199-202
• 33 Wachtfogel YT, Kucich U, James HL. et al Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest 1983; 72: 1672-1677
• 34 Schmaier AH, Schutsky D, Farber A, Silver LD, Bradford HN, Colman RW. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains. J Biol Chem 1987; 262: 1405-1411
• 35 Carvalho AC, DeMarinis S, Scott CF, Silver LD, Schmaier AH, Colman RW. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome. J Lab Clin Med 1988; 112: 270-277
• 36 Schapira M, Silver LD, Scott CF. et al Prekallikrein activation and high molecular weight kininogen consumption in hereditary angioedema. N Engl J Med 1983; 308: 1050-1053
• 37 Wong PY, Williams GH, Colman RW. Studies on the renin-angiotensin system in a kininogen-deficient individual. Clin Sci 1983; 65: 121-126
• 38 Raja SN, Campbell JN, Meyer RA, Colman RW. Role of kinins in pain and hyperalgesia: Psychophysical studies in a patient with kininogen deficiency. Clin Sci 1992 (in press)
• 39 Scott CF, Pixley RA, Colman RW. A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate. Thromb Res 1987; 48: 685-700
• 40 Scott CF, Colman RW. Sensitive antigenic determinations of high molecular weight kininogen (HK) using covalent coupling of capture antibody. J Lab Clin Med 1992; 119: 77-86